Sigachi acquired shares in Trimax Bio Sciences, converting an existing loan. This follows Trimax Bio Sciences receiving a Certificate of Suitability for Metformin Hydrochloride from EDQM, enabling exports to Europe and other regulated markets, strengthening Sigachi's position in key pharmaceutical ingredient supply. Sigachi Industries also approved a ₹0.10 per share dividend, subject to approval.